Author

Yangyang Liu

First Affiliated Hospital of Zhengzhou UniversityORCID 0000-0001-8296-7095Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yangyang Liu1 paper

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ge ZhangiD· 1 shared Guanxing PaniD· 1 shared Haoxuan ZhongiD· 1 shared Hu HuiD· 1 shared Jianjun Zhang· 1 shared Jianzeng DongiD· 1 shared Lin ChangiD· 1 shared Ruyi XueiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ge ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyJournal of the American Heart AssociationPeer-reviewedJun 24, 2025

ER stress-induced TREM2 downregulation exacerbates platelet activation and myocardial infarction in patients with coronary artery disease

Xiaowen Wu, Guanxing Pan, Lin Chang…·Zhongren Ding

This study identifies TREM2 as a signaling hub linking ER stress, immune-inflammation, and platelet hyperactivity in CAD, showing that TREM2 downregulation exacerbates myocardial infarction and that TREM2-activating antibodies may offer therapeutic potential.

7 citationstop 4%

humanproteomics

𝕏 PostBluesky